Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...
However, Recursion’s earnings per share (EPS) fell short, posting an actual EPS of -$0.41 against the forecasted -$0.35, resulting in a 17.14% negative surprise. Additionally, Recursion ...
Recursion Pharmaceuticals’s stock price closed at $5.00. It is down -6.72% in the last 3 months and down -28.26% in the last 12 months. Recursion Pharmaceuticals saw 0 positive EPS revisions and 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback